{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:49:22Z","timestamp":1791838162977,"version":"4.3.4"},"reference-count":63,"publisher":"Oxford University Press (OUP)","issue":"suppl_2","funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7,15]]},"DOI":"10.1093\/infdis\/jix132","type":"journal-article","created":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T07:07:40Z","timestamp":1492758460000},"page":"S412-S419","source":"Crossref","is-referenced-by-count":96,"title":["New Horizons in Mycoplasma genitalium Treatment"],"prefix":"10.1093","volume":"216","author":[{"given":"Catriona S","family":"Bradshaw","sequence":"first","affiliation":[{"name":"Central Clinical School, Monash University, and"},{"name":"Melbourne Sexual Health Centre, Alfred Hospital, Melbourne, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorgen S","family":"Jensen","sequence":"additional","affiliation":[{"name":"Microbiology and Infection Control, Statens Serum Institut, Copenhagen, Denmark; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken B","family":"Waites","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,7,27]]},"reference":[{"key":"key\n\t\t\t\t20180306120614_CIT0001","volume-title":"Methods for antimicrobial susceptibility testing of human mycoplasmas. Approved guideline","author":"M43-A","year":"2011"},{"key":"key\n\t\t\t\t20180306120614_CIT0002","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/cid\/cit752","article-title":"High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options","volume":"58","author":"Pond","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180306120614_CIT0003","doi-asserted-by":"crossref","first-page":"e61481","DOI":"10.1371\/journal.pone.0061481","article-title":"Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic","volume":"8","author":"Anagrius","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180306120614_CIT0004","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/jdv.13849","article-title":"2016 European guideline on Mycoplasma genitalium infections","volume":"30","author":"Jensen","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key\n\t\t\t\t20180306120614_CIT0005","first-page":"20","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm Rep 2015"},{"key":"key\n\t\t\t\t20180306120614_CIT0006","doi-asserted-by":"crossref","first-page":"S802","DOI":"10.1093\/cid\/civ785","article-title":"Efficacy of antimicrobial therapy for Mycoplasma genitalium infections","volume":"61","author":"Manhart","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180306120614_CIT0007","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrurol.2016.268","article-title":"Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium","volume":"14","author":"Unemo","year":"2017","journal-title":"Nat Rev Urol"},{"key":"key\n\t\t\t\t20180306120614_CIT0008","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1128\/JCM.00125-13","article-title":"Development of doxycycline MIC and disk diffusion interpretive breakpoints and revision of tetracycline breakpoints for Streptococcus pneumoniae","volume":"51","author":"Dallas","year":"2013","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180306120614_CIT0009","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/sti.2007.027375","article-title":"Antibiotic treatment of symptomatic Mycoplasma genitalium infection in Scandinavia: a controlled clinical trial","volume":"84","author":"Bj\u00f6rnelius","year":"2008","journal-title":"Sex Transm Infect"},{"key":"key\n\t\t\t\t20180306120614_CIT0010","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1258\/ijsa.2008.008038","article-title":"Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study","volume":"19","author":"Jernberg","year":"2008","journal-title":"Int J STD AIDS"},{"key":"key\n\t\t\t\t20180306120614_CIT0011","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/sextrans-2014-051616","article-title":"Positivity at test of cure following first-line treatment for genital Mycoplasma genitalium: follow-up of a clinical cohort","volume":"91","author":"Gundevia","year":"2015","journal-title":"Sex Transm Infect"},{"key":"key\n\t\t\t\t20180306120614_CIT0012","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciw719","article-title":"Azithromycin 1.5 g over 5 days compared to 1 g single dose in urethral Mycoplasma genitalium: impact on treatment outcome and resistance","author":"Read","year":"2017;","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180306120614_CIT0013","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1086\/599033","article-title":"A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men","volume":"48","author":"Mena","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180306120614_CIT0014","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/cid\/ciq074","article-title":"Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens\u2014a randomized clinical trial","volume":"52","author":"Schwebke","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180306120614_CIT0015","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/cid\/cis1022","article-title":"Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial","volume":"56","author":"Manhart","year":"2013","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180306120614_CIT0016","volume-title":"Australasian Sexual Health Alliance","author":"Australian STI Management Guidelines"},{"key":"key\n\t\t\t\t20180306120614_CIT0017","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/cid\/civ644","article-title":"The efficacy of azithromycin for the treatment of genital Mycoplasma genitalium: a systematic review and meta-analysis","volume":"61","author":"Lau","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180306120614_CIT0018","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/cid\/ciu1162","article-title":"Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens","volume":"60","author":"Bissessor","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180306120614_CIT0019","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s12879-015-1041-6","article-title":"Management of Mycoplasma genitalium infections\u2014can we hit a moving target?","volume":"15","author":"Jensen","year":"2015","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180306120614_CIT0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2334-11-35","article-title":"The difference in determinants of Chlamydia trachomatis and Mycoplasma genitalium in a sample of young Australian women","volume":"11","author":"Walker","year":"2011","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180306120614_CIT0021","first-page":"e96","article-title":"Mycoplasma genitalium in Toronto, Ont: Estimates of prevalence and macrolide resistance","volume":"62","author":"Gesink","year":"2016","journal-title":"Can Fam Physician"},{"key":"key\n\t\t\t\t20180306120614_CIT0022","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1128\/JCM.01053-16","article-title":"Mycoplasma genitalium prevalence, coinfection, and macrolide antibiotic resistance frequency in a multicenter clinical study cohort in the United States","volume":"54","author":"Getman","year":"2016","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180306120614_CIT0023","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.diagmicrobio.2016.07.005","article-title":"Emergence of Mycoplasma genitalium strains showing mutations associated with macrolide and fluoroquinolone resistance in the region Dresden, Germany","volume":"86","author":"Dumke","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20180306120614_CIT0024","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1128\/AAC.00724-09","article-title":"Antimicrobial susceptibilities of Mycoplasma genitalium strains examined by broth dilution and quantitative PCR","volume":"53","author":"Hamasuna","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180306120614_CIT0025","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1128\/AAC.02411-14","article-title":"In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains","volume":"58","author":"Jensen","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180306120614_CIT0026","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3201\/eid1207.051558","article-title":"Azithromycin failure in Mycoplasma genitalium urethritis","volume":"12","author":"Bradshaw","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20180306120614_CIT0027","volume-title":"2014 UK National Guideline on the Management of Non-gonococcal Urethritis","author":"Horner"},{"key":"key\n\t\t\t\t20180306120614_CIT0028","first-page":"956462416688562","article-title":"Meta-analysis of the efficacy of moxifloxacin in treating Mycoplasma genitalium infection","author":"Li","year":"2017","journal-title":"Int J STD AIDS"},{"key":"key\n\t\t\t\t20180306120614_CIT0029","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijantimicag.2010.05.011","article-title":"Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance","volume":"36","author":"Shimada","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20180306120614_CIT0030","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1128\/JCM.00495-13","article-title":"Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium","volume":"51","author":"Tagg","year":"2013","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20180306120614_CIT0031","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1177\/0956462413502008","article-title":"Failure of moxifloxacin treatment in Mycoplasma genitalium infections due to macrolide and fluoroquinolone resistance","volume":"24","author":"Couldwell","year":"2013","journal-title":"Int J STD AIDS"},{"key":"key\n\t\t\t\t20180306120614_CIT0032","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1093\/jac\/dku164","article-title":"Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan","volume":"69","author":"Kikuchi","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180306120614_CIT0033","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s10156-013-0620-y","article-title":"Clinical efficacy of sitafloxacin 100 mg twice daily for 7 days for patients with non-gonococcal urethritis","volume":"19","author":"Takahashi","year":"2013","journal-title":"J Infect Chemother"},{"key":"key\n\t\t\t\t20180306120614_CIT0034","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s10156-012-0392-9","article-title":"Clinical and microbiological outcomes in treatment of men with non-gonococcal urethritis with a 100-mg twice-daily dose regimen of sitafloxacin","volume":"18","author":"Ito","year":"2012","journal-title":"J Infect Chemother"},{"key":"key\n\t\t\t\t20180306120614_CIT0035","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jiac.2014.08.021","article-title":"Sitafloxacin: antimicrobial activity against ciprofloxacin-selected laboratory mutants of Mycoplasma genitalium and inhibitory activity against its DNA gyrase and topoisomerase IV","volume":"21","author":"Deguchi","year":"2015","journal-title":"J Infect Chemother"},{"key":"key\n\t\t\t\t20180306120614_CIT0036","volume-title":"European Medicines Agency recommends restricting the use of oral moxifloxacin-containing medicines (press release)","author":"European Medicines Agency","year":"2008"},{"key":"key\n\t\t\t\t20180306120614_CIT0037","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/phar.1367","article-title":"Risk of acute liver injury associated with the use of moxifloxacin and other oral antimicrobials: a retrospective, population-based cohort study","volume":"34","author":"Kaye","year":"2014","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t20180306120614_CIT0038","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijmm.2013.08.008","article-title":"Streptogramins\u2014two are better than one!","volume":"304","author":"Mast","year":"2014","journal-title":"Int J Med Microbiol"},{"key":"key\n\t\t\t\t20180306120614_CIT0039","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1128\/AAC.36.4.870","article-title":"In vitro susceptibilities of Mycoplasma genitalium to antibiotics","volume":"36","author":"Renaudin","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180306120614_CIT0040","volume-title":"Efficacy of pristinamycin for treatment resistant Mycoplasma genitalium","author":"Read"},{"key":"key\n\t\t\t\t20180306120614_CIT0041","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1099\/00222615-47-12-1115","article-title":"Comparative susceptibilities of various AIDS-associated and human urogenital tract mycoplasmas and strains of Mycoplasma pneumoniae to 10 classes of antimicrobial agent in vitro","volume":"47","author":"Hannan","year":"1998","journal-title":"J Med Microbiol"},{"key":"key\n\t\t\t\t20180306120614_CIT0042","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/jac\/dkw405","article-title":"Successful outcome of macrolide-resistant Mycoplasma genitalium urethritis after spectinomycin treatment: a case report","volume":"72","author":"Falk","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180306120614_CIT0043","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/00007435-198410001-00042","article-title":"Clinical evaluation of thiamphenicol in treatment of nongonococcal urethritis","volume":"11","author":"Saito","year":"1984","journal-title":"Sex Transm Dis"},{"key":"key\n\t\t\t\t20180306120614_CIT0044","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00007435-198410001-00037","article-title":"Thiamphenicol for treatment of salpingitis","volume":"11","author":"Vige","year":"1984","journal-title":"Sex Transm Dis"},{"key":"key\n\t\t\t\t20180306120614_CIT0045","first-page":"533","article-title":"In vitro antibacterial activity of thiamphenicol glycinate acetylcysteinate against respiratory pathogens","volume":"49","author":"Albini","year":"1999","journal-title":"Arzneimittelforschung"},{"key":"key\n\t\t\t\t20180306120614_CIT0046","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/infdis\/145.4.583","article-title":"Comparison of spectinomycin, cefuroxime, thiamphenicol, and penicillin G in the treatment of uncomplicated gonococcal infections in women","volume":"145","author":"Tupasi","year":"1982","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180306120614_CIT0047","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1159\/000220702","article-title":"Diffusion of thiamphenicol in the bronchial secretions and in the lung tissue","volume":"15","author":"Cambieri","year":"1970","journal-title":"Chemotherapy"},{"key":"key\n\t\t\t\t20180306120614_CIT0048","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1128\/AAC.00090-09","article-title":"Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101","volume":"53","author":"Waites","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180306120614_CIT0049","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/cid\/civ478","article-title":"A phase 2 trial of oral solithromycin 1200 mg or 1000 mg as single-dose oral therapy for uncomplicated gonorrhea","volume":"61","author":"Hook","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180306120614_CIT0050","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1128\/AAC.01343-09","article-title":"In vitro activity of CEM-101, a new fluoroketolide antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae","volume":"54","author":"Roblin","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180306120614_CIT0051","volume-title":"In vitro activities of investigational ketolide WCK 4873 (nafithromycin) and other antimicrobial agents against human mycoplasmas and ureaplasmas","author":"Waites"},{"key":"key\n\t\t\t\t20180306120614_CIT0052","doi-asserted-by":"crossref","first-page":"e02008","DOI":"10.1128\/AAC.02008-16","article-title":"In vitro activity of lefamulin and other antimicrobial agents against macrolide-susceptible and macrolide-resistant Mycoplasma pneumoniae from the United States, Europe, and China","volume":"61","author":"Waites","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180306120614_CIT0053","volume-title":"In vitro activity of the novel pleuromutilin BC-3781 tested against bacterial pathogens causing sexually transmitted diseases (STD)","author":"Paukner"},{"key":"key\n\t\t\t\t20180306120614_CIT0054","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1128\/AAC.01734-16","article-title":"In vitro activities of omadacycline (PTK 0796) and other antimicrobial agents against human mycoplasmas and ureaplasmas","volume":"60","author":"Waites","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180306120614_CIT0055","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1128\/AAC.01383-07","article-title":"In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens","volume":"52","author":"Lawrence","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180306120614_CIT0056","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1128\/AAC.47.12.3973-3975.2003","article-title":"Comparative in vitro susceptibilities and bactericidal activities of investigational fluoroquinolone ABT-492 and other antimicrobial agents against human mycoplasmas and ureaplasmas","volume":"47","author":"Waites","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180306120614_CIT0057","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1128\/AAC.04945-14","article-title":"In vitro antibacterial activity of AZD0914 against human mycoplasmas and ureaplasmas","volume":"59","author":"Waites","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180306120614_CIT0058","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1128\/AAC.04124-14","article-title":"In vitro antibacterial activity of AZD0914, a new spiropyrimidinetrione DNA gyrase\/topoisomerase inhibitor with potent activity against gram-positive, fastidious gram-negative, and atypical bacteria","volume":"59","author":"Huband","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180306120614_CIT0059","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.1128\/AAC.01016-15","article-title":"In vitro activity of AZD0914, a novel bacterial DNA Gyrase\/topoisomerase IV inhibitor, against clinically relevant gram-positive and fastidious gram-negative pathogens","volume":"59","author":"Biedenbach","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180306120614_CIT0060","volume-title":"Comparative in vitro activity of gepotidacin and other antimicrobial agents against human mycoplasmas and ureaplasmas","author":"Waites"},{"key":"key\n\t\t\t\t20180306120614_CIT0061","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/cid\/civ312","article-title":"Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis","volume":"61","author":"Lis","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180306120614_CIT0062","doi-asserted-by":"crossref","DOI":"10.3201\/eid2305.161745","article-title":"Macrolide and fluoroquinolone resistance in Mycoplasma genitalium","author":"Murray","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20180306120614_CIT0063","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/sextrans-2015-052414","article-title":"Should azithromycin 1\u2005g be abandoned as a treatment for bacterial STIs? The case for and against","volume":"93","author":"Horner","year":"2017","journal-title":"Sex Transm Infect"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/216\/suppl_2\/S412\/24264533\/jix132.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T15:29:16Z","timestamp":1658935756000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/216\/suppl_2\/S412\/4040966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,15]]},"references-count":63,"journal-issue":{"issue":"suppl_2","published-online":{"date-parts":[[2017,7,27]]},"published-print":{"date-parts":[[2017,7,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jix132","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732206636.793539864","asserted-by":"object"}]},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,7,15]]},"published":{"date-parts":[[2017,7,15]]}}}